Effect of Iron-fortified Pea Powder on Exercise Performance
- Conditions
- Iron-deficiency
- Interventions
- Dietary Supplement: Placebo (maltodextrin)Dietary Supplement: Regular pea powderDietary Supplement: Low phytate pea powder
- Registration Number
- NCT04872140
- Lead Sponsor
- University of Saskatchewan
- Brief Summary
Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance. This study assesses the impact of an pea protein supplement with high iron bio-availability on iron status and exercise performance.
- Detailed Description
Female endurance athletes are susceptible to iron deficiency due to poor iron intake from diets or possibly because of destruction of red blood cells during foot-strike hemolysis. This study will evaluate the impact of 8-weeks of iron supplementation through consumption of a pea-protein power that has high iron bio-availability due to low phytate levels. This will be compared to consumption of regular iron protein powder and maltodextrin placebo by randomizing participants to three groups. Participants will be assessed at baseline and after 8 weeks of supplementation for exercise performance (maximal aerobic capacity and a 5 km time trial running test), blood levels of ferritin and hemoglobin, and body composition (fat mass and lean tissue mass).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 28
- Female
- Regularly participate in aerobic endurance training
- Any contra-indications to exercise testing as determined with the "Get Active Questionnaire"
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo (maltodextrin) Placebo (maltodextrin) powder (0g iron per day) Pea powder Regular pea powder Pea powder with normal phytate levels (7mg iron per day) Pea power with high iron bio-availability Low phytate pea powder Pea powder with low phytate levels to increase iron bio-availability (7mg iron per day)
- Primary Outcome Measures
Name Time Method Change from baseline in ferritin levels Up to 8 weeks blood ferritin levels
- Secondary Outcome Measures
Name Time Method Change from baseline in hemoglobin levels Up to 8 weeks Blood hemoglobin concentration
Change from baseline in lean tissue mass Up to 8 weeks Lean tissue mass (kg) measured with dual energy X-ray absorptiometry
Change from baseline in maximal aerobic capacity Up to 8 weeks Maximal aerobic capacity (mL/kg/min) measured on a treadmill
Change from baseline in exercise time trial performance Up to 8 weeks Time (minutes) to complete 5 km running on a treadmill
Change from baseline in fat mass Up to 8 weeks Fat mass (kg) measured with dual energy X-ray absorptiometry
Trial Locations
- Locations (1)
University of Saskatchewan
🇨🇦Saskatoon, Saskatchewan, Canada